Abstract
Crimean-Congo hemorrhagic fever virus (CCHFV) is a deadly virus that has been listed in the Category C as a potential bioterror agent. There are no specific therapies against CCHFV, which urges identification of potential therapeutic targets and development of CCHFV therapies. CCHFV OTU protease takes an important role in viral invasion through antagonizing NF-κB signaling. Inhibition of CCHFV OTU protease by small molecules warrants an exciting potential as antiviral therapeutics. Here we report the expression and purification of a C-His-tagged recombinant CCHFV OTU protease in E. coli BL21 (DE3) host strain. Activity of the refolded purified recombinant viral OTU protease has been validated with a UB-AMC fluorescent assay. In addition, we show a dose-dependent inhibition of the viral OTU protease by two small molecules. This study provides a reliable approach for recombinant expression and purification of CCHFV OTU protease, and demonstrates validation of OTU protease activity and its inhibition based on a UB-AMC florescent assay.
Graphical Abstract
Similar content being viewed by others
References
N. Frias-Staheli, N.V. Giannakopoulos, M. Kikkert, S.L. Taylor, A. Bridgen, J. Paragas, J.A. Richt, R.R. Rowland, C.S. Schmaljohn, D.J. Lenschow, E.J. Snijder, A. García-Sastre, H.W. Virgin, Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2(6), 404–416 (2007)
D.A. Bente, N.L. Forrester, D.M. Watts, A.J. McAuley, C.A. Whitehouse, M. Bray, Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 100, 159–189 (2013)
G.C. Capodagli, M.K. Deaton, E.A. Baker, R.J. Lumpkin, S.D. Pegan, Diversity of ubiquitin and ISG15 specificity among nairoviruses’ viral ovarian tumor domain proteases. J. Virol. 87, 3815–3827 (2013)
K. Ergunay, C.A. Whitehouse, A. Ozkul, Current status of human arboviral diseases in Turkey. Vector Borne Zoonotic Dis. 11, 731–741 (2011)
G.C. Capodagli, M.A. McKercher, E.A. Baker, E.M. Masters, J.S. Brunzelle, S.D. Pegan, Structural analysis of a viral ovarian tumor domain protease from the crimean-congo hemorrhagic fever virus in complex with covalently bonded ubiquitin. J. Virol. 85, 3621–3630 (2011)
E. Ozkaya, E. Dincer, A. Carhan, Y. Uyar, M. Ertek, C.A. Whitehouse, A. Ozkul, Molecular epidemiology of Crimean-Congo hemorrhagic fever virus in Turkey: occurrence of local topotype. Virus Res. 149, 64–70 (2010)
B. Holzer, S. Bakshi, A. Bridgen, M.D. Baron, Inhibition of interferon induction and action by the nairovirus Nairobi sheep disease virus/Ganjam virus. PLoS One 6(12), e28594 (2011)
C.A. Whitehouse, Crimean-Congo hemorrhagic fever. Antiviral Res. 64, 145–160 (2004)
M. Akutsu, Y. Ye, S. Virdee, J.W. Chin, D. Komander, Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains. Proc. Natl. Acad. Sci. 108, 2228–2233 (2011)
O.A. Malakhova, D.-E. Zhang, ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J. Biol. Chem. 283, 8783–8787 (2008)
O. Ergonul, Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr. Opin. Virol. 2, 215–220 (2012)
A. Gargili, K. Midilli, O. Ergonul, S. Ergin, H.G. Alp, Z. Vatansever, S. Iyisan, C. Cerit, G. Yilmaz, K. Altas, A. Estrada-Peña, Crimean-Congo hemorrhagic fever in European part of Turkey: genetic analysis of the virus strains from ticks and a seroepidemiological study in humans. Vector Borne Zoonotic Dis. 11, 747–752 (2011)
B. Dokuzoguz, A.K. Celikbas, S.E. Gök, N. Baykam, M.N. Eroglu, O. Ergonul, Severity scoring index for crimean-congo hemorrhagic Fever and the impact of ribavirin and corticosteroids on fatality. Clin. Infect. Dis. 57, 1270–1274 (2013)
O. Ergonul, A.K. Celikbas, B. Dokuzoguz, S.E. Gök, N. Baykam, H. Esener, Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin. Infect. Dis. 39(2), 284–287 (2004)
M. Lindeborg, C. Barboutis, C. Ehrenborg, T. Fransson, T.G.T. Jaenson, P.-E. Lindgren, A. Lundkvist, F. Nyström, E. Salaneck, J. Waldenström, B. Olsen, Migratory birds, ticks, and Crimean-Congo hemorrhagic fever virus. Emerg. Infect. Dis. 18, 2095–2097 (2012)
A.M. Palomar, A. Portillo, P. Santibáñez, D. Mazuelas, J. Arizaga, A. Crespo, Ó. Gutiérrez, J.F. Cuadrado, J.A. Oteo, Crimean-Congo hemorrhagic fever virus in ticks from migratory birds. Morocco. Emerg. Infect. Dis. 19, 260–263 (2013)
P. Gale, B. Stephenson, A. Brouwer, M. Martinez, A. la de Torre, J. Bosch, M. Foley-Fisher, P. Bonilauri, A. Lindström, R.G. Ulrich, J. de Vos, M. Scremin, L. Kelly, Z. Liu, M.J. Muñoz, Impact of climate change on risk of incursion of Crimean-Congo haemorrhagic fever virus in livestock in Europe through migratory birds. J. Appl. Microbiol. 112, 246–257 (2012)
F. Weber, A. Mirazimi, Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis. Cytokine Growth Factor Rev. 19, 395–404 (2008)
M.D. Arguello, J. Hiscott, Ub surprised: viral ovarian tumor domain proteases remove ubiquitin and ISG15 conjugates. Cell Host Microbe 2, 367–369 (2007)
P.B. van Kasteren, C. Beugeling, D.K. Ninaber, Arterivirus and nairovirus ovarian tumor domain-containing deubiquitinases target activated RIG-I to control innate immune signaling. J. Virol. 86(2), 773–785 (2012)
T.W. James, N. Frias-Staheli, J.-P. Bacik, J.M. Levingston Macleod, M. Khajehpour, A. García-Sastre, B.L. Mark, Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease. Proc. Natl. Acad. Sci. 108, 2222–2227 (2011)
E. Kinsella, S.G. Martin, A. Grolla, M. Czub, H. Feldmann, R. Flick, Sequence determination of the Crimean-Congo hemorrhagic fever virus L segment. Virology 321(1), 23–28 (2004)
P. Puigbò, E. Guzmán, A. Romeu, S. Garcia-Vallvé, OPTIMIZER: a web server for optimizing the codon usage of DNA sequences. Nucleic Acids Res. 35, W126–W131 (2007)
E.E. Bolton, Y. Wang, P.A. Thiessen, S.H. Bryant, PubChem: integrated platform of small molecules and biological activities. Annu. Rep. Comput. Chem. 4, 217–241 (2008)
Y. Wang, J. Xiao, T.O. Suzek, J. Zhang, J. Wang, Z. Zhou, L. Han, K. Karapetyan, S. Dracheva, B.A. Shoemaker, E. Bolton, A. Gindulyte, S.H. Bryant, PubChem’s bioassay database. Nucleic Acids Res. 40, D400–D412 (2011)
O. Trott, A.J. Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31(2), 455–461 (2009)
M.F. Sanner, A.J. Olson, J.C. Spehner, Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 38, 305–320 (1996)
M.F. Sanner, Python: a programming language for software integration and development. J. Mol. Graph. Model. 17, 57–61 (1999)
T. Matsunaga, Y. Morikawa, M. Haga, S. Endo, M. Soda, K. Yamamura, O. El-Kabbani, K. Tajima, A. Ikari, A. Hara, Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10. Toxicol. Appl. Pharmacol. 278, 180–189 (2014)
X.M. Cotto-Rios, M. Békés, J. Chapman, B. Ueberheide, T.T. Huang, Deubiquitinases as a signaling target of oxidative stress. Cell Rep. 2, 1475–1484 (2012)
E. Bergeron, C.G. Albarino, M.L. Khristova, S.T. Nichol, Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function. J. Virol. 84, 216–226 (2010)
Acknowledgments
We thank Dr. Savas Kaya from Immunology Department, School of Medicine, Dicle University, Diyarbakir Turkey for his valuable input regarding MGLTools, and Autodock Vina. We thank Dr. Andrew J. Harvey from the Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul, Turkey for his critical reading of the manuscript. We thank the support from Co-Funded Brain Circulation Scheme by The Scientific and Technological Research Council of Turkey (TÜBİTAK) and The Marie Curie Action COFUND of the 7th. Framework Programme (FP7) of the European Commission Grant#115C039, The Science Academy Young Scientist Award Program (BAGEP-2015, Turkey), funds provided by North American University, Houston, USA and Yeditepe University, Istanbul, Turkey.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflicts of interest concerning this work.
Additional information
Edited by Paul Schnitzler.
Electronic supplementary material
Below is the link to the electronic supplementary material.
11262_2015_1226_MOESM1_ESM.pdf
pET26b(+) vector was linearized with NdeI and NcoI enzymes. This was followed by In-Fusion cloning (Clontech) of linearized vector and two gene fragments (about 315-320 base pair long) with homology sequences. Supplementary material 1 (PDF 65 kb)
Rights and permissions
About this article
Cite this article
Kocabas, F., Aslan, G.S. Fluorometric CCHFV OTU protease assay with potent inhibitors. Virus Genes 51, 190–197 (2015). https://doi.org/10.1007/s11262-015-1226-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11262-015-1226-5